Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-01 Sale | 2021-11-03 4:11 pm | Merck & Co. Inc. | MRK | Gerberding Julie L. EVP, Chief Patient Officer | 96,270 | $87.91 | $8,462,682 | 71,691 (Direct) | View |
| 2020-07-17 Sale | 2020-07-20 4:53 pm | Merck & Co. Inc. | MRK | Gerberding Julie L. EVP Strat Comm, GI Pub Policy | 36,285 | $80 | $2,902,976 | 26,577 (Direct) | View |
| 2020-01-13 Sale | 2020-01-15 5:15 pm | Merck & Co. Inc. | MRK | Gerberding Julie L. EVP Strat Comm, GI Pub Policy | 102,073 | $89.34 | $9,118,865 | 37,038 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-07 Option Award | 2023-06-09 6:41 pm | N/A 2033-06-06 | HilleVax Inc. | HLVX | Gerberding Julie L. Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2022-08-19 Option Award | 2022-08-23 4:36 pm | N/A 2032-08-18 | HilleVax Inc. | HLVX | Gerberding Julie L. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-06-07 Equity Swap | 2022-06-09 5:24 pm | N/A N/A | CERNER Corp | CERN | Gerberding Julie L. Director | 15,032 | $95 | 0 (Direct) | View |
Ownership | 2022-04-28 9:45 pm | N/A N/A | HilleVax Inc. | HLVX | Gerberding Julie L. Director | 0 | $0 | 42,025 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-28 4:17 pm | N/A N/A | Merck & Co. Inc. | MRK | Gerberding Julie L. EVP, Chief Patient Officer | 9,550 | $73.51 | 48,712 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-03 4:11 pm | 2018-05-05 2027-05-04 | Merck & Co. Inc. | MRK | Gerberding Julie L. EVP, Chief Patient Officer | 96,270 | $0 | 71,691 (Direct) | View |
Ownership | 2021-08-11 8:16 pm | N/A N/A | AfterNext HealthTech Acquisition Corp. | AFTR | Gerberding Julie L. Director | 0 | $0 | 40,000 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 5:29 pm | N/A N/A | CERNER Corp | CERN | Gerberding Julie L. Director | 3,188 | $0 | 15,032 (Direct) | View |
| 2021-05-04 Option Award | 2021-05-06 4:43 pm | 2022-05-04 2031-05-03 | Merck & Co. Inc. | MRK | Gerberding Julie L. EVP Strat Comm, GI Pub Policy | 39,796 | $0 | 78,958 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 11:46 am | N/A N/A | Merck & Co. Inc. | MRK | Gerberding Julie L. EVP Strat Comm, GI Pub Policy | 12,585 | $72.62 | 39,162 (Direct) | View |
| 2020-07-17 Exercise | 2020-07-20 4:53 pm | 2017-05-10 2026-05-09 | Merck & Co. Inc. | MRK | Gerberding Julie L. EVP Strat Comm, GI Pub Policy | 18,111 | $0 | 26,577 (Direct) | View |
| 2020-05-22 Option Award | 2020-05-27 4:12 pm | N/A N/A | CERNER Corp | CERN | Gerberding Julie L. Director | 3,716 | $0 | 11,844 (Direct) | View |
| 2020-05-01 Option Award | 2020-05-05 4:45 pm | 2021-05-01 2030-04-30 | Merck & Co. Inc. | MRK | Gerberding Julie L. EVP Strat Comm, GI Pub Policy | 33,226 | $0 | 77,977 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 5:30 pm | N/A N/A | Merck & Co. Inc. | MRK | Gerberding Julie L. EVP Strat Comm, GI Pub Policy | 7,371 | $76.56 | 44,409 (Direct) | View |
| 2020-01-13 Exercise | 2020-01-15 5:15 pm | 2016-05-01 2025-04-30 | Merck & Co. Inc. | MRK | Gerberding Julie L. EVP Strat Comm, GI Pub Policy | 82,548 | $0 | 37,038 (Direct) | View |